ShowcasesPricing
  1. US-listed companies
  2. Akero Therapeutics, Inc.

Akero Therapeutics, Inc.AKRO

Market cap
$1.1B
P/E ratio
Income statementBalance sheetCash flowOther
Raw aggregated data